• Cat-intel
  • MedIntelliX
  • Resources
  • About Us
  • Request Free Sample ×

    Kindly complete the form below to receive a free sample of this Report

    Leading companies partner with us for data-driven Insights

    clients tt-cursor

    Contrast Media Market

    ID: MRFR/LS/0776-HCR
    90 Pages
    Rahul Gotadki
    September 2025

    Contrast Media Market Research Report Information By Type (Iodinated Contrast Media, Gadolinium-Based Contrast Media), By Form (Tablet, Powder, Liquid, Paste), By Procedures (X-ray/Computed Tomography, Magnetic Resonance Imaging), By Application (Cardiovascular Disease, Oncology, Gastrointestinal Disorders), And By Region (North America, Europe, Asia-Pacific, And Rest Of The World) – Market Forecast Till 2032

    Share:
    Download PDF ×

    We do not share your information with anyone. However, we may send you emails based on your report interest from time to time. You may contact us at any time to opt-out.

    Contrast Media Market Infographic
    Purchase Options
    $ 4,950.0
    $ 5,950.0
    $ 7,250.0

    Contrast Media Market Summary

    As per Market Research Future Analysis, the Global Contrast Media Market was valued at USD 6.36 Billion in 2023 and is projected to grow to USD 18.23 Billion by 2032, with a CAGR of 4.76% from 2024 to 2032. The market is driven by the increasing number of diagnostic procedures and the rising popularity of minimally invasive treatments. Iodinated contrast agents dominate the market due to their extensive use in X-ray and CT imaging, enhancing visualization of various internal organs. The demand for innovative imaging solutions and image-guided procedures is further propelling market growth.

    Key Market Trends & Highlights

    The Contrast Media Market is witnessing significant growth driven by advancements in diagnostic imaging and increasing healthcare needs.

    • Market Size in 2023: USD 6.36 Billion; projected to reach USD 18.23 Billion by 2032.
    • CAGR of 4.76% during the forecast period (2024-2032).
    • Iodinated contrast agents accounted for the largest market share in 2022.
    • North America held a market share of USD 1.4 Billion in 2022.

    Market Size & Forecast

    2023 Market Size USD 6.36 Billion
    2032 Market Size USD 18.23 Billion
    CAGR 4.76%

    Major Players

    Key players include Bayer AG, Bracco Diagnostic Inc, GE Healthcare, Guerbet Group, and Lantheus Medical Imaging Inc.

    Contrast Media Market Trends

    Growing Demand for Diagnostics Imaging to boost the market growth

    Chronic diseases of many types are prevalent ly, and the demand for diagnostic imaging is at an all-time high. Imaging services per Medicare beneficiary saw the highest increase in the number of imaging services per Medicare beneficiary of all other services provided by physicians, according to a report from the Medicare Payment Advisory Council (MedPAC) to the Centers for Medicare and Medicaid Services (CMS).

    Image-guided surgery (IGS) is gaining acceptance over time. These procedures are useful in diagnosing and treating a variety of conditions. The growing demand for imaging refinement during surgery requires unique data acquisition, processing, display methods, and a comprehensive understanding of the imaging process and its application in therapy. Image-guided procedures are well addressing this need, which has led to an increase in demand for diagnosis and treatment, thus acting as a factor is further enhanced the market CAGR of contrast media across the globe in recent years.

    Healthcare professionals and people worldwide are increasingly embracing minimally invasive therapies and image-guided procedures. Ultrasonography has undergone a considerable transformation from traditional diagnostic imaging in obstetrics and gynecology to treating kidney stones, malignancies, and other clinical conditions. These initiatives will likely create new opportunities for manufacturers in the market of contrast media to increase revenue. The market for contrast media has the potential to become more attractive owing to the increasing public demand for diagnostic imaging services and the increasing availability of various diagnostic imaging modalities.

    Moreover, marketing companies in the contrast media market are launching new cutting-edge technologies and high-quality products with cutting-edge features.

    The increasing use of medical imaging is increasing the market demand for the contrast media and enhancing the market growth of the Contrast Media.

    The increasing prevalence of chronic diseases and the growing demand for advanced imaging techniques are driving the expansion of the global contrast media market, reflecting a critical evolution in diagnostic capabilities.

    U.S. Food and Drug Administration (FDA)

    Contrast Media Market Drivers

    Rising Demand for Diagnostic Imaging

    The Global Contrast Media Market Industry experiences a notable surge in demand for diagnostic imaging procedures, driven by the increasing prevalence of chronic diseases and the aging population. As healthcare systems globally prioritize early diagnosis and treatment, the utilization of contrast media in imaging techniques such as MRI and CT scans becomes essential. In 2024, the market is projected to reach 6.74 USD Billion, reflecting the growing reliance on advanced imaging technologies. This trend is expected to continue, with the market potentially expanding to 21.0 USD Billion by 2035, indicating a robust CAGR of 10.86% from 2025 to 2035.

    Market Segment Insights

    Contrast Media Type Insights

    In the Contrast Media market segmentation, based on type, iodinated contrast media, gadolinium-based contrast media. The iodinated contrast agents segment accounted for the largest market share in 2022, which can be attributed to the high penetration rate of X-ray and C.T. procedures and the availability of non-ionically stable iodinated agents for improved diagnosis. Iodine-containing contrast agents are usually given intravenously; however, in some cases, they are replaced by barium-based contrast agents for oral and rectal administration. Iodine-based contrast agents are used to enhancing C.T. and X-ray images.

    They enhance visualization of the gastrointestinal tract, internal organs, arteries and veins, soft tissues, and the brain. Iodinated contrast agents are used in various indications, including neurological, renal, gastrointestinal, cardiovascular and musculoskeletal disorders and cancer. Thus, the  contrast media market revenue is increasing.

    Figure 2:  Contrast Media Market, by Type, 2023 & 2032 (USD Billion)

    Source: Secondary Research, Primary Research, Market Research Future Database and Analyst Review

    Contrast Media Form Insights

    The Contrast Media market segmentation, The market has been segmented based on form into liquid, tablet, powder, and paste. The target audience prefers all these forms according to the requirements of the product.

    Contrast Media Procedures Insights

    The Contrast Media market data, based on procedures, X-ray/Computed Tomography (CT), Magnetic Resonance Imaging (MRI). Among these, the X-ray/C.T. contrast agents help generate high-resolution 3D images of structures. Barium-based and iodinated contrast agents are used in X-ray and C.T. techniques. When barium and iodine contrast agents are administered/injected into the body, they block X-rays and don't allow them to pass through. As a result, organs, blood vessels, and other body tissues that temporarily contain barium-based or iodinated contrast media change in appearance. X-ray and C.T. are widely used in several diseases and are expected to stimulate market growth.

    Contrast Media Application Insights

    The application-based market data of contrast media includes cardiovascular disease, oncology, and gastrointestinal disorders. The fertilizer category holds the major market share. The cardiovascular diseases (CVD) segment is expected to account for a large revenue share during the forecast period. This is due to the increasing prevalence of cardiovascular diseases worldwide. According to the National Center for Biotechnology Information (NCBI), the disease is expected to affect 6 to 12 Billion people worldwide by 2050 and 17.9 Billion in Europe by 2060. Moreover, the increasing prevalence of cardiovascular diseases generates a huge demand for innovations in the contrast media industry.

    News

    April 2023, Japanese researchers investigated if switching the ICM that initially triggered an adverse reaction in a patient to a different agent could lessen the chance of a further adverse reaction. Data analysis showed that patients who had experienced an ICM-induced hypersensitive reaction before were 61% less likely to experience a repeat reaction if they switched ICMs. Independent efforts have been made to enhance reaction documentation at the Mayo Clinic and elsewhere. Adoption by other hospitals would be aided by standardizing this procedure.

    According to a preliminary analysis that was carried out by the firm in June 2023, the magnetic resonance imaging (MRI) contrast agent SN132D that was developed by Spago NanoMedical was shown to be well tolerated in patients who suffered from endometriosis. Spago Nanomedical claims that the drug has an excellent safety profile, despite the fact that further study of its MRI contrast-enhancing characteristics in lesions indicative of deep endometriosis is required.

    Get more detailed insights about Contrast Media Market Research Report - Global Forecast till 2032

    Regional Insights

    By Region, the study provides market insights into North America, Europe, Asia-Pacific and the Rest of the World. The North America Contrast Media market accounted for USD 1.4 billion in 2022 and is expected to exhibit a significant CAGR growth during the study period. Market growth is expected to accelerate due to various strategic initiatives by major manufacturers targeting niche patient subsets in this segment. Key players in the market include Bayer, GE Healthcare, Guerbet, Lantheus, and Bracco Diagnostics.

    Further, the major countries studied in the market report are The U.S., Canada, Germany, France, the U.K., Italy, Spain, China, Japan, India, Australia, South Korea, and Brazil.

    Figure 3:  CONTRAST MEDIA MARKET SHARE BY REGION 2022 (%)

    CONTRAST MEDIA MARKET SHARE BY REGION 2022

    Source: Secondary Research, Primary Research, Market Research Future Database and Analyst Review

    The European contrast media market region is expected to take second place. The product demand in the region is growing owing to rising healthcare spending, the presence of more medical device companies in the region, and the growing market revenue in the region. Moreover, UK market of contrast media held the largest market share, and the Germany market of contrast media was the fastest-growing market in the European region.

    The Asia Pacific contrast media market will also account for a large share in 2022. This can be attributed to well-established local and foreign manufacturers in the Region region. For example, G.E. Pharmaceuticals (Shanghai) Co., Ltd. is a branch of G.E. in China for diagnostic drugs (CT/MR contrast agents), and it is one of the largest production bases of G.E. Healthcare in the world for contrast agents. This factor is expected to continue to drive regional market growth.

    Moreover, China market of contrast media held the largest market share, and the India market of contrast media was the fastest-growing market in the region.

    Key Players and Competitive Insights

    Major market players are investing heavily in research and development to increase their product lines, which will help the market of contrast media to grow further. The market players have also undertaken several strategic initiatives to expand their footprints, including key market developments such as new product launches, contractual agreements, mergers and acquisitions, increasing investments, and collaborations with other organizations. Competitors in the Contrast Media industry must offer cost-effective products to expand and survive in the increasingly competitive and rising market environment.

    One of the key business strategies adopted by the manufacturers in the Contrast Media agents industry to benefit their customers and expand their market segment is to manufacture locally to reduce operating costs. In recent years, the Contrast Media industry has provided some of the most significant benefits to medicine. Major players in the market of Contrast Media, such as Bayer AG (Germany), Bracco Diagnostic Inc (U.S.), DAIICHI (Japan), NANOSCAN IMAGING (U.S.), Jodas Expoim (India), G.E.

    Healthcare (U.S.), Guerbet Group (France), Lantheus Medical Imaging Inc (U.S.), Taejoon Pharm (Korea), Magnus Health (U.S.) are focusing on expanding the market demand by investing in research and development activities.

    Beijing Beilu Pharmaceutical Co., Ltd. is engaged in the research and development, production and sales of pharmaceutical products. The company's products include Iopamidol Injection, Iodixanol Injection, Repaglinide Tablets and other contrast agent series, and psychiatric and hypoglycemic products. In February 2022, Hokuri Pharmaceutical's loperamide passed the consistency evaluation of generic drugs. The assessment helps to review the quality and efficacy of generic drugs compared to brand-name drugs.

    Also, Bayer AG is a German multinational pharmaceutical and biotechnology company and one of the largest pharmaceutical companies in the world. Headquartered in Leverkusen, Bayer's business areas include pharmaceuticals, consumer healthcare, agrochemicals, seeds and biotechnology products. In July 2020, Bayer and Siemens Healthineers presented a new imaging system interface (ISI) for magnetic resonance imaging. The interface combines Bayer's MRXperion MR injection system with a Siemens Healthineers MR scanner to overcome challenges faced by traditional methods.

    Key Companies in the Contrast Media Market market include

    Industry Developments

    October 2022: G.E. Healthcare's pharmaceutical diagnostics company announced a long-term agreement with the Chilean mining company Sociedad Quimica y Minera (SQM) de Chile S.A. to guarantee its supply of iodine, which is used in X-ray contrast media products. Vital components and computed tomography procedures around the world. As part of G.E. Healthcare's larger commitment and investment plan, this will help SQM expand its supply of iodine raw material year-on-year, producing an additional 30 Billion doses of iodine contrast media per year by 2025.

    December 2021: The previously announced G.E. Healthcare acquisition of B.K. Medical was finalized. With this acquisition, G.E. Healthcare has enhanced its pre- and post-operative ultrasound capabilities to cover real-time surgical observation, a fast-growing and relatively new discipline.

    Future Outlook

    Contrast Media Market Future Outlook

    The Global Contrast Media Market is projected to grow at a 10.86% CAGR from 2024 to 2035, driven by technological advancements, increasing diagnostic imaging demand, and rising healthcare expenditures.

    New opportunities lie in:

    • Develop novel contrast agents for specific imaging modalities to enhance diagnostic accuracy.
    • Leverage AI and machine learning for personalized imaging solutions and improved patient outcomes.
    • Expand distribution networks in emerging markets to capture growing healthcare investments.

    By 2035, the Global Contrast Media Market is expected to achieve substantial growth, reflecting evolving healthcare needs and technological innovations.

    Market Segmentation

    Contrast Media Form Outlook

    • Tablet
    • Powder
    • Liquid
    • Paste

    Contrast Media Type Outlook

    • Iodinated Contrast Media
    • Gadolinium-Based Contrast Media

    Contrast Media Regional Outlook

    North America
    • US
    • Canada

    Contrast Media Procedure Outlook

    • X-ray/Computed Tomography (C.T.)
    • Magnetic Resonance Imaging (MRI)
    • Swine

    Contrast Media Application Outlook

    • Cardiovascular Disease
    • Oncology
    • Gastrointestinal Disorders

    Report Scope

    Attribute/Metric Details
    Market Size 2023 USD 6.36 billion
    Market Size 2024 USD 6.74 billion
    Market Size 2032 USD 18.23 billion
    Compound Annual Growth Rate (CAGR) 4.76% (2024-2032)
    Base Year 2023
    Market Forecast Period 2024-2032
    Historical Data 2018 & 2021
    Market Forecast Units Value (USD Billion)
    Report Coverage Revenue Forecast, Market Competitive Landscape, Growth Factors, and Trends
    Segments Covered Type, Form, Procedures, Application, and Region
    Geographies Covered North America, Europe, Asia Pacific, and the Rest of the World
    Countries Covered The U.S, Canada, Germany, France, the U.K., Italy, Spain, China, Japan, India, Australia, South Korea, and Brazil
    Key Companies Profiled Bayer AG (Germany), Bracco Diagnostic Inc (U.S.), DAIICHI (Japan), NANOSCAN IMAGING (U.S.), Jodas Expoim (India), G.E. Healthcare (U.S.), Guerbet Group (France), Lantheus Medical Imaging Inc (U.S.), Taejoon Pharm (Korea), Magnus Health (U.S.)
    Key Market Opportunities Increasing research on contrast agents.
    Key Market Dynamics Growing prevalence of chronic diseases. The rising popularity of minimally invasive procedures.

    Market Highlights

    Author
    Rahul Gotadki
    Assistant Manager

    He holds an experience of about 7+ years in Market Research and Business Consulting, working under the spectrum of Life Sciences and Healthcare domains. Rahul conceptualizes and implements a scalable business strategy and provides strategic leadership to the clients. His expertise lies in market estimation, competitive intelligence, pipeline analysis, customer assessment, etc. In addition to the above, his other responsibility includes strategic tracking of high growth markets & advising clients on the potential areas of focus they could direct their business initiatives

    Leave a Comment

    FAQs

    What is the market size for contrast media?

    The contrast media market size was valued at USD 6.36 billion in 2023 and is projected to grow from USD 6.74 Billion in 2024 to USD 18.23 billion by 2032

    Which factors drives the contrast media market?

    Growing Demand for Diagnostics Imaging drives the global contrast media market

    What are the types of contrast media?

    Iodinated Contrast Media, Gadolinium-Based Contrast Media are the types of contrast media

    Which region is expected to dominate the contrast media market?

    North America is expected to dominate the global contrast media market

    Who makes contrast media?

    Major players in the market of Contrast Media, such as Bayer AG (Germany), Bracco Diagnostic Inc (U.S.), DAIICHI (Japan), NANOSCAN IMAGING (U.S.), Jodas Expoim (India), G.E. Healthcare (U.S.), Guerbet Group (France), Lantheus Medical Imaging Inc (U.S.), Taejoon Pharm (Korea), Magnus Health (U.S.)

    Contrast Media Market Research Report - Global Forecast till 2032 Infographic
    Free Sample Request

    Kindly complete the form below to receive a free sample of this Report

    Customer Stories

    “I am very pleased with how market segments have been defined in a relevant way for my purposes (such as "Portable Freezers & refrigerators" and "last-mile"). In general the report is well structured. Thanks very much for your efforts.”

    Victoria Milne Founder
    Case Study
    Chemicals and Materials